Eric Fakra
Overview
Explore the profile of Eric Fakra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
618
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gerentes M, Lajnef M, Szoke A, Aouizerate B, Berna F, Clery M, et al.
Drug Saf
. 2025 Mar;
PMID: 40088341
Background: The life expectancy of patients with schizophrenia is reduced, partly due to cardiovascular diseases. Antipsychotics are associated with QT interval prolongation, which is a risk factor for arrhythmia and...
2.
Barbosa S, Tamouza R, Leboyer M, Aouizerate B, Andrieu C, Andre M, et al.
Prog Neuropsychopharmacol Biol Psychiatry
. 2025 Mar;
137:111304.
PMID: 40023308
Background: Schizophrenia (SZ) commonly manifests through multiple relapses, each impeding the path to recovery and incurring personal and societal costs. Despite the identification of various risk factors associated to the...
3.
Palmer T, Kadri K, Fakra E, Scholl J, Fouragnan E
PLoS One
. 2024 Dec;
19(12):e0309357.
PMID: 39636885
Much work has investigated beneficial effects of mindfulness-based meditation methods, but less work has investigated potential risks and differences across meditation methods. We addressed this in a large pre-registered online...
4.
Blandin A, Dallel S, Degry J, Fakra E, Hardy S, Liothier J, et al.
Encephale
. 2024 May;
51(1):95-99.
PMID: 38724432
Psychiatric wards that only exceptionally use isolation and mechanical restraint may be suspected of using "chemical restraint". However, in the case of these services, the hypothesis of a reduction in...
5.
Amiot O, Sauvaget A, Alamome I, Bulteau S, Charpeaud T, Clair A, et al.
JMIR Form Res
. 2024 Apr;
8:e53204.
PMID: 38568139
Background: Major depressive disorder is one of the leading causes of disability worldwide. Although most international guidelines recommend psychological and psychosocial interventions as first-line treatment for mild to moderate depression,...
6.
Fiorito A, Blasi G, Brunelin J, Chowdury A, Diwadkar V, Goghari V, et al.
Schizophrenia (Heidelb)
. 2024 Mar;
10(1):38.
PMID: 38503766
Schizophrenia is characterized by the misattribution of emotional significance to neutral faces, accompanied by overactivations of the limbic system. To understand the disorder's genetic and environmental contributors, investigating healthy first-degree...
7.
Leclerc L, Fakra E, Pignon B, Benyamina A, Gaillard R, Rolland B
Encephale
. 2024 Feb;
50(6):597-602.
PMID: 38311481
Objective: To explore the opinions of French psychiatrists toward the legalization of medical or recreational use of cannabis in France. Methods: Psycan was an anonymous Internet survey conducted between September...
8.
Fiorito A, Fakra E, Sescousse G, Ibrahim E, Rey R
Transl Psychiatry
. 2023 Dec;
13(1):386.
PMID: 38092734
Besides playing a central role in neuroinflammation, microglia regulate synaptic development and is involved in plasticity. Converging lines of evidence suggest that these different processes play a critical role in...
9.
Courtet P, Amiot O, Baca-Garcia E, Bellardita L, Cerveri G, Clair A, et al.
Eur Psychiatry
. 2023 Oct;
66(1):e82.
PMID: 37872705
Depressive disorders represent the largest proportion of mental illnesses, and by 2030, they are expected to be the first cause of disability-adjusted life years [1]. The COVID-19 pandemic exacerbated prevalence...
10.
Argote M, Sescousse G, Brunelin J, Baudin G, Schaub M, Rabin R, et al.
EClinicalMedicine
. 2023 Sep;
64:102199.
PMID: 37731936
Background: The association between cannabis use and positive symptoms in schizophrenia spectrum disorders is well documented, especially via meta-analyses. Yet, findings are inconsistent regarding negative symptoms, while other dimensions such...